[1] |
DEWEY F E, GROVE M E, PAN C, et al. Clinical interpretation and implications of whole-genome sequencing[J]. JAMA, 2014, 311(10):1035-1045.
DOI
PMID
|
[2] |
LAU T K, CHEUNG S W, LO P S, et al. Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA:review of 1982 consecutive cases in a single center[J]. Ultrasound Obstet Gynecol, 2014, 43(3):254-264.
|
[3] |
姚如恩, 傅启华, 郁婷婷. 全基因组测序技术在临床诊断中的应用[J]. 国际检验医学杂志, 2023, 44(17):2049-2052.
|
[4] |
李蕾, 李存玺, 虞京葳. 美国临床遗传检测实验室监管机制[J]. 中华医学遗传学杂志, 2019, 36(1):23-27.
|
[5] |
VASSY J L, CHRISTENSEN K D, SCHONMAN E F, et al. The impact of whole-genome sequencing on the primary care and outcomes of healthy adult patients:a pilot randomized trial[J]. Ann Intern Med, 2017, 167(3):159-169.
|
[6] |
RICHARDS S, AZIZ N, BALE S, et al. Standards and guidelines for the interpretation of sequence variants:a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]. Genet Med, 2015, 17(5):405-424.
|
[7] |
GHOSH R, HARRISON S M, REHM H L, et al. Updated recommendation for the benign stand-alone ACMG/AMP criterion[J]. Hum Mutat, 2018, 39(11):1525-1530.
DOI
PMID
|
[8] |
ABOU TAYOUN A N, PESARAN T, DISTEFANO M T, et al. Recommendations for interpreting the loss of function PVS1 ACMG/AMP variant criterion[J]. Hum Mutat, 2018, 39(11):1517-1524.
DOI
PMID
|
[9] |
BRNICH S E, ABOU TAYOUN A N, COUCH F J, et al. Recommendations for application of the functional evidence PS3/BS3 criterion using the ACMG/AMP sequence variant interpretation framework[J]. Genome Med, 2019, 12(1):3.
DOI
PMID
|
[10] |
PEJAVER V, BYRNE A B, FENG B J, et al. Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3/BP4 criteria[J]. Am J Hum Genet, 2022, 109(12):2163-2177.
DOI
PMID
|
[11] |
BIESECKER L G, HARRISON S M, ClinGen Sequence Variant Interpretation Working Group. The ACMG/AMP reputable source criteria for the interpretation of sequence variants[J]. Genet Med, 2018, 20(12):1687-1688.
DOI
PMID
|
[12] |
中华预防医学会出生缺陷预防与控制专业委员会产前筛查和诊断学组. 孕前及孕早期常见隐性单基因遗传病携带者筛查临床应用专家共识[J]. 中华围产医学杂志, 2024, 27(1):3-12.
|
[13] |
AMINBEIDOKHTI M, QU J H, BELUR S, et al. Miscarriage risk assessment:a bioinformatic approach to identifying candidate lethal genes and variants[J]. Hum Genet, 2024, 143(2):185-195.
|
[14] |
GRZYMSKI J J, ELHANAN G, MORALES ROSADO J A, et al. Population genetic screening efficiently identifies carriers of autosomal dominant diseases[J]. Nat Med, 2020, 26(8):1235-1239.
DOI
PMID
|
[15] |
中国遗传学会遗传诊断分会, 上海市遗传学会临床遗传与遗传咨询专委会. 综合性携带者筛查关键问题专家共识(2024版)[J]. 国际遗传学杂志, 2024, 47(1):1-11.
|
[16] |
JANSEN I E, SAVAGE J E, WATANABE K, et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk[J]. Nat Genet, 2019, 51(3):404-413.
DOI
PMID
|
[17] |
MARS N, LINDBOHM J V, DELLA BRIOTTA PAROLO P, et al. Systematic comparison of family history and polygenic risk across 24 common diseases[J]. Am J Hum Genet, 2022, 109(12):2152-2162.
DOI
PMID
|
[18] |
DE ROJAS I, MORENO-GRAU S, TESI N, et al. Common variants in Alzheimer's disease and risk stratification by polygenic risk scores[J]. Nat Commun, 2021, 12(1):3417.
DOI
PMID
|